BESHORE DOUGLAS C has a total of 11 patent applications. Its first patent ever was published in 2010. It filed its patents most often in United States. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are MORPHIC THERAPEUTIC INC, GIRARDET JEAN-LUC and AHMED KAMAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Beshore Douglas C | 11 |
#2 | Kuduk Scott D | 10 |
#3 | Skudlarek Jason W | 2 |
#4 | Garbaccio Robert M | 2 |
#5 | Johnson Adam W | 2 |
#6 | Kukuk Scott D | 1 |
#7 | Dimarco Christina Ng | 1 |
#8 | Wang Cheng | 1 |
#9 | Shu Youheng | 1 |
#10 | Yang Zhi-Qiang | 1 |
Publication | Filing date | Title |
---|---|---|
US2013102599A1 | Pyrazolo [4,3-C] cinnolin-3-one M1 receptor positive allosteric modulators | |
US2014088151A1 | Alhydroxymethyl biaryl benzotriazole derivatives | |
US2014066443A1 | Aminomethyl biaryl benzotriazole derivatives | |
US2012135977A1 | Ether benzotriazole derivatives | |
US2013040959A1 | Heterocyclic quinolizine derived M1 receptor positive allosteric modulators | |
US2012178760A1 | Heterocyclic-fused pyrazolo[4,3-c]pyridin-3-one M1 receptor positive allosteric modulators |